GSK leads European charge into Yankee land of plenty
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
Corporate Bonds

GSK leads European charge into Yankee land of plenty

The depth of the US corporate bond market and its razor-sharp appetite for high grade credit were vividly apparent this week as GlaxoSmithKline issued its first bond for three years, in an apparently effortless $5bn three tranche sale.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article